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Abstract
Purpose:  To  compare  the  enhancement  dynamics  of  osteoid  osteomas  with  other  benign  and
malignant  lytic  bone  lesions  using  CT  perfusion.
Patients  and  methods:  CT  perfusion  parameters  of  15  patients  with  a  ﬁnal  diagnosis  of  osteoid
osteoma,  15  patients  with  lesions  that  mimic  osteoid  osteomas  and  26  patients  with  other  bone
lytic lesions  were  compared.
Results:  Enhancement  curve  morphology  of  the  osteoid  osteomas  was  signiﬁcantly  different
from its  mimickers.  All  osteoid  osteomas  had  an  early  enhancement  with  a  delay  between  nidus
and arterial  peak  below  30  seconds.  Eighty  percent  of  the  mimickers  demonstrated  a  slow  and
progressive  enhancement.  The  perfusion  parameters  of  the  other  lytic  bone  lesions  were  similar
to those  of  the  osteoid  osteomas  in  46.1%  of  the  patients.
Conclusion:  Early  enhancement  is  suggestive  but  not  pathognomonic  of  osteoid  osteomas.
Absent or  delayed  enhancement  in  similar  lesions  should  evoke  an  alternative  diagnosis.  The
same contrast  enhancement  dynamics  of  osteoid  osteomas  can  be  seen  in  other  bone  lesions,
both malignant  and  benign.
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Osteoid  osteomas  are  a  relatively  frequent  benign  bone
umor  of  children  and  young  adults  that  typically  causes
hronic  inﬂammatory  type  pain  [1—3]. The  imaging  diag-
osis  of  osteoid  osteomas  is  based  on  the  identiﬁcation  of
 small  translucent  nidus,  with  a  central  calciﬁcation  and
 marked  reactive  sclerosis  surrounding  it.  These  features
an  be  identiﬁed  on  conventional  radiographs  but  computed
omography  (CT)  remains  the  method  of  choice  for  the  diag-
osis  [4].
The  diagnosis  of  typical  osteoid  osteomas  is  usually
traightforward.  These  lesions  however,  may  lack  its  dis-
inctive  features,  especially  when  they  are  intra-articular
r  located  in  the  small  carpal  or  tarsal  bones  [5].  Imaging
eatures  of  osteoid  osteomas  are  less  characteristic  and  may
e  misleading  with  magnetic  resonance  (MR)  imaging  [6,7].
dditionally,  other  conditions  such  as  sub-acute  osteomyeli-
is  (brodie’s  abcess),  stress  fractures  and  other  intra-  or
eri-cortical  bone  neoplasms  may  be  difﬁcult  to  differen-
iate  from  osteoid  osteomas  [1,5].
The  evaluation  of  contrast  enhancement  dynamics  has
een  shown  to  increase  the  accuracy  of  the  non-invasive
iagnosis  of  osteoid  osteomas  [8,9].  Enhancement  curves
ith  an  early  enhancement  and  a  distinct  washout  or  with
 plateau  were  described  for  osteoid  osteomas  [9].  This
nhancement  pattern,  however,  has  not  yet  been  compared
o  that  of  potential  osteoid  osteomas  mimickers  or  to  that
f  other  lytic  bone  lesions.  Other  lytic  bone  lesions  with
 similar  enhancement  pattern  might  hinder  the  diagno-
is  of  osteoid  osteomas  and  may  be  a  potential  source  of
iagnostic  error.
CT  is  frequently  used  for  the  evaluation  of  lytic  bone
esions.  Low  dose  CT  perfusion  may  have  a  role  in  the  char-
cterization  and  pre-operative  planning  of  these  patients.  In
ome  countries,  there  is  still  a  non-negligible  waiting  time
or  an  MR  examination.  In  France,  the  mean  delay  for  an  MR
xamination  is  32  days,  and  it  can  be  as  high  as  50  days
epending  on  the  region.  Hence  the  use  of  CT  perfusion
ould  be  interesting  to  expedite  the  diagnosis  of  a  lytic  bone
esion.  The  use  of  iterative  reconstruction  algorithms  and
arge  area  detector  CT  systems  to  perform  perfusion  lead  to
 major  reduction  in  radiation  dose  exposure  which  allows
he  use  of  this  technique  in  selected  patients  [10—12]. The
urpose  of  this  study  is  to  compare  the  CT  perfusion  param-
ters  (curve  morphology,  time-to-peak,  and  delay  between
rterial  and  tumor  peaks)  of  osteoid  osteomas  to  that  of
ther  lytic  bone  lesions.
aterial and methods
atients
ifty-four  patients  who  underwent  CT  perfusion  at  our
nstitution  from  January  2010  to  February  2012  were
rospectively  evaluated.  This  study,  which  includes  MR  and
T  evaluations  both,  was  approved  by  the  local  ethics  com-
ittee  and  the  AFSSAPS  (French  FDA  equivalent).  These
atients  had  been  referred  for  the  evaluation  of  lytic  bone
esions.  All  patients  were  over  18  years  old  and  signed  an
nformed  consent  for  all  the  imaging  studies  performed.
ifteen  of  these  patients  had  a  ﬁnal  diagnosis  of  osteoid
steomas  (osteoid  osteoma  group).  15  of  these  patients  had
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ony  lesions  with  conventional  CT  features  suggestive  of
steoid  osteoma  but  the  diagnosis  of  osteoid  osteoma  was
uled  out  by  other  imaging  methods  and/or  clinical  or  his-
ological  ﬁndings  (mimickers  group).  The  other  26  patients
ad  a  histologically  conﬁrmed  lytic  bone  lesion  other  than
steoid  osteomas  (other  tumors  group).  MR  imaging  with
equences  before  and  after  injection  of  a  gadolinium  based
ontrast  media  was  performed  in  all  patients  included.
The  osteoid  osteoma  group  was  composed  of  12  males  and
 females  with  an  age  range  of  19  to  52  years.  In  all  patients
f  the  osteoid  osteoma  group  were  treated  with  percuta-
eous  laser  therapy  or  radiofrequency  ablation.  None  of
hese  patients  have  been  previously  treated.  Bone  biopsy
as  performed  with  11  to  14G  needles  at  the  same  time
f  treatment  for  all  patients.  All  patients  demonstrated  a
ood  response  to  the  percutaneous  treatment  with  a  return
o  normal  activities  no  residual  diurnal  or  nocturnal  pain
wo  months  after  treatment.  Histologic  evaluation  of  the
one  fragments  yielded  histological  conﬁrmation  of  osteoid
steoma  in  7  patients.  In  the  remaining  8  patients,  the  his-
ologic  diagnosis  of  osteoid  osteoma  was  not  reached.  The
iagnostic  conﬁrmation  in  these  cases  was  based  on  its  imag-
ng  characteristics,  clinical  ﬁndings,  response  to  therapy  and
bsence  of  an  alternative  diagnosis  at  histologic  analysis.
he  imaging  signs  considered  as  inclusion  criteria  and  that
ere  present  in  all  patients  in  the  osteoid  osteoma  group
ere:  hypodense  lesion  on  CT  (nidus)  smaller  than  2  cm;
clerotic  bone  reaction  adjacent  to  the  lesion;  inﬂamma-
ory  type  reactive  changes  on  T2-weighted  fat-saturated
round  the  nidus  and  detectable  nidus  enhancement  at  MR.
ll  patients  were  examined  and  interviewed  by  a  radiolo-
ist  (A.B.)  with  21  years  of  clinical  experience  before  and
fter  percutaneous  treatment.  The  clinical  ﬁndings  used  as
nclusion  criteria  and  presented  by  all  patients  were:  chronic
on-mechanical  pain  for  more  than  6 months;  pain  worse
t  night;  pain  relieved  by  aspirin.  All  the  patients  without
 histologic  diagnosis  were  followed  for  at  least  2  months
fter  treatment.  The  bone  biopsies  of  these  patients  yielded
ormal  or  sclerotic  cortical  tissue.  The  osteoid  osteomas
ncluded  were  located  at:  shoulder  (2  patients),  forearm,
lbow,  lumbar  spine  (3  patients),  hip  (2  patients),  around
he  knee  (4  patients)  and  foot  and  ankle  region  (2  patients).
The  mimickers  group  was  composed  of  6  males  and
 females  with  an  age  range  of  21  to  65  years.  These
atients  had  been  referred  for  the  investigation  of  bone
umors.  The  inclusion  criteria  for  this  group  were:  a  small
ortical/sub-cortical  lytic  bone  lesion  (13  cases)  or  an  impor-
ant  bone/periosteal  sclerosis  without  a well  deﬁned  lytic
esion  (2  cases)  and  a  ﬁnal  diagnosis  other  than  osteoid
steoma.  Lesions  larger  than  2  cm  in  the  long  axis  and  with-
ut  a  cortical  or  sub-cortical  location  were  excluded  from
his  group.
In  eight  of  the  patients  included  in  the  mimickers  group,
ercutaneous  bone  biopsy  yielded  a  diagnosis  other  than
steoid  osteoma.  In  two  patients,  bone  biopsy  revealed
nly  normal  bone  tissue.  One  had  a  sclerotic  bone  reac-
ion  related  to  a  systemic  inﬂammatory  disease  conﬁrmed  by
ther  imaging  ﬁndings  (bilateral  sacroiliitis).  Imaging  follow
p  in  this  patient  demonstrated  a  near  complete  regression
f  the  lesion  after  medicamentous  treatment.  The  second
atient  had  an  extra-articular  lytic  bone  lesion  of  the  distal
emur  with  no  bone  marrow  edema,  no  reactive  sclerosis  and
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5CT  perfusion  of  osteoid  osteomas  and  mimickers  
no  uptake  in  SPECT  CT.  These  ﬁndings  rule  out  the  diagnosis
of  osteoid  osteoma  with  reasonable  conﬁdence.
The  other  ﬁve  patients  included  in  the  mimickers  group
had  no  histologic  conﬁrmation.  One  of  these  patients  had
an  odd  appearing  bone  stress  reaction  found  to  regress  on
an  imaging  control  after  the  cessation  of  excessive  physical
activity.  The  other  four  patients  had  benign  appearing  lytic
bone  lesions  with  regular  contours,  no  cortical  rupture  and
no  invasion  of  the  adjacent  soft  tissues  (no  touch  lesions).
These  patients  were  either  asymptomatic  (1  patient)  or
presented  discomfort  (3  patients)  that  was  not  clearly  asso-
ciated  with  the  bone  lesion.  In  these  patients,  the  imaging
aspect  of  these  lesions  did  not  warrant  a  bone  biopsy.  In  one
patient,  the  lytic  bone  lesion  disappeared  spontaneously  in
the  control  study  leaving  a  sclerotic  bone  reaction  at  its
place.  Patients  without  sufﬁcient  evidence  to  exclude  the
diagnosis  of  osteoid  osteoma  beyond  reasonable  doubt  were
excluded.
The  other  tumors  group  was  composed  of  26  patients  with
lytic  bone  lesions  of  larger  than  2  cm  in  any  location  with  a
ﬁnal  diagnosis  other  then  osteoid  osteoma  conﬁrmed  either
by  percutaneous  or  surgical  biopsy.  This  group  was  composed
of  15  males  and  11  females  with  an  age  range  of  20  to  86
years.
Patients  with  metallic  artifacts  in  the  studied  region,
with  a  known  malignancy  diagnosed  elsewhere  and  with
known  metastatic  disease  were  excluded.  Patients  under  18
years  old  were  not  allowed  to  sign  the  informed  consent  and
were  also  excluded.
Imaging protocol
All  studies  were  performed  in  a  CT  scanner  with  a  large
detector  system  composed  of  320-detector  row  (Aquil-
ion  ONE,  Toshiba  Medical  Systems,  Otawara,  Japan).  The
patients  with  lesions  located  in  the  extremities  were
immobilized  with  an  inﬂatable  splint.  Perfusion  study  was
performed  with  an  intermittent  acquisition  mode  with  no
table  feed.  The  protocol  included  14-16  volumes  (Tube  rota-
tion:  0.5  s,  slice  thickness:  0.5  mm,  matrix  of  512  ×  512).
The  ﬁrst  10  volumes  were  acquired  with  a  5  second
delay  between  them  (arterial  phase).  The  last  4-6  vol-
umes  were  acquired  with  a  10  second  delay  between  them
(venous  phase).  Tube  output  parameters  were  adapted  to
the  anatomic  region.  A  dual  injection  pump  (Stellant  D,
Medrad  INC,  Indianola,  PA,  USA)  was  used  for  contrast  injec-
tion.  Iomeron® 400  (Bracco  Imaging,  Evry,  France),  with  a
concentration  of  400  mg/ml  was  injected  in  all  patients.
A  total  of  150  ml  was  injected  in  a  single  bolus  through  a
peripheral  venous  access  (18  G  cannula)  with  an  injection
rate  of  5  ml/s.  Acquisition  started  5  seconds  after  contrast
injection.  Total  examination  length  was  dependent  on  the
number  of  volumes  and  varied  from  85  to  105  seconds.  The
coverage  in  the  z  axis  varied  from  4  to  8  cm.
MR  was  performed  with  a  GE  Healthcare  1.5  T  Signa  HDxt
scanner  using  dedicated  coils.  MR  studies  were  performed
within  less  than  a  week  delay  from  the  CT  perfusion  study.
Conventional  sequences  were  acquired  and  included  at  least
one  T1  weighted  sequence  and  T2  fat-saturated  sequences
in  two  different  orthogonal  planes.  Gadolinium  was  injected
in  all  patients.  T2-weighted  fat-saturated  FSE  images  were
used  for  the  identiﬁcation  of  bone  marrow  edema.
(
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mage analysis and post processing
wo  fellowship  trained  radiologists  with  21  and  5  years
f  clinical  experience  in  musculoskeletal  radiology  post
rocessed  all  the  images.  CT  perfusion  images  from  the
atients  included  were  post  processed  using  the  AW  console
ersion  4.4  GE  Healthcare  in  the  same  manner.  The  ROIs
ere  placed  inside  the  center  of  the  lytic  lesion  and  in  a
earby  artery  in  axial  0.5  mm  images.  In  the  osteoid  osteoma
nd  the  mimickers  group,  the  slice  that  depicted  the  largest
ortion  of  the  lytic  lesion  was  selected  for  the  whole  eval-
ation.  The  ROIs  were  sized  and  positioned  to  occupy  the
argest  area  of  the  bone  lysis.  In  the  two  patients,  with  bone
clerosis  and  no  visible  lytic  lesion  the  ROI  was  placed  in
east  dense  part  of  the  sclerosis.  In  the  other  tumors  group,
he  ROIs  were  positioned  in  the  region  of  maximal  tumor
nhancement.  Time-to-density  curves  were  constructed.
Curve  morphology  analysis  was  bases  on  the  classiﬁca-
ion  proposed  by  Van  Rijswijk  et  al.  [13].  Type  I designates
 ﬂat  curve,  type  II  a progressive  enhancement  with  no
nhancement  peak,  type  III  an  enhancement  peak  followed
y  a  plateau,  type  IV  an  enhancement  peak  followed  by
 washout  and  type  V  an  enhancement  peak  followed  by
 progressive  enhancement.  The  analysis  of  the  perfusion
arameters  was  performed  in  consensus.  Semi-quantitative
T  perfusion  parameters  (time-to-peak,  delay  between  the
rterial  and  lesion  peaks)  were  calculated  every  time  a  peak
f  enhancement  was  identiﬁed  (curves  type  III,  IV  and  V).
hese  parameters  were  not  calculated  for  curves  type  I  or
I.  Curves  type  I  represent  no  detectable  enhancement.  With
espect  to  curves  type  II,  the  time-to-peak  and  the  delay
etween  the  arterial  and  lesion  peaks  are  entirely  deﬁned
y  the  length  of  the  acquisition,  since  the  tumor  proba-
ly  continues  to  enhance  after  the  end  of  the  acquisition.
nhancement  was  considered  signiﬁcant  if  an  increase  of
ore  than  15  Hounsﬁeld  units  (HU)  was  detected.
All  conventional  CT  were  evaluated  in  a  PACS  station
Impax  V5,  AGFA  HealthCare,  Ivry-sur-Seine,  France).  The
isher  exact  test  was  used  for  the  analysis  of  the  statisti-
al  signiﬁcance  of  the  variation  in  curve  types  amongst  the
hree  different  groups.  The  Students  exact  T  test  was  used
or  the  analysis  of  the  statistical  signiﬁcance  of  quantitative
ata.  A  P  value  less  than  0.05  was  used  as  the  threshold  for
tatistical  signiﬁcance.
esults
ll  the  nidi  of  the  osteoid  osteoma  group  showed  a
etectable  enhancement  on  CT  perfusion.  Nidus  size  varied
rom  0.3  to  1.8  cm.  All  the  lesions  in  this  group  presented
n  enhancement  peak.  In  12  lesions  the  enhancement  curve
as  classiﬁed  as  type  IV  and  in  three  as  type  III.  In  the
steoid  osteoma  group,  the  time-to-peak  varied  from  35  to
5  seconds,  with  a  mean  of  49.0  (±14.6)  seconds.  The  lesion
ith  an  85  second  time-to-peak  had  an  osteoid  osteoma  of
he  forefoot,  explaining  the  longer  delay  with  respect  to
he  other  lesions.  The  delay  to  the  arterial  peak  varied  from
—25  seconds  in  this  with  a  mean  of  12.2  (±7.5)  seconds
Table  1).
In the  mimickers  group,  the  lesion  size  varied  from  0.3  to
.9  cm,  six  of  them  had  a  central  calciﬁcation.  Five  of  the
esions  in  this  group  did  not  show  a  detectable  enhancement
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n  CT  perfusion  (curve  type  I).  In  the  other  10  lesions,  the
nhancement  was  detected  on  CT  perfusion.  The  enhance-
ent  curve  was  classiﬁed  as  type  II  in  seven  cases,  as  type  III
n  one  case  and  as  type  IV  in  two  cases  (Table  1).  In  the  later
hree  cases  (curved  types  III  and  IV)  the  time-to-peak  val-
es  were  60,  35  and  35  seconds  with  a  mean  of  43.3  (±14.0)
nd  the  delays  between  the  arterial  and  tumor  peak  were
,  25  and  5  seconds  with  a  mean  of  11.6  (±11.5)  seconds.
n  osteomyelitis,  a  chondrosarcoma  and  a  benign  appearing
symptomatic  lytic  bone  lesion  with  no  histologic  diagnosis
ere  the  ﬁnal  diagnosis  in  the  cases  with  curves  types  III
nd  IV.  Eighty  percent  of  the  lesions  in  this  group  presented
urve  types  I  or  II.  The  differences  in  curve  type  between
he  osteoid  osteoma  group  and  the  mimicker’s  group  were
tatistically  signiﬁcant  (P  <  0.0001)  (Table  2).
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Table  1  Perfusion  characteristics  of  the  lesions  included  in  th
Location  Curve  Tim
Patient  1  Knee  IV  44  
Patient  2  Elbow  III  60  
Patient  3  Knee  IV  60  
Patient  4  Knee  IV  50  
Patient  5  Shoulder  IV  50  
Patient  6  Fore  arm  IV  45  
Patient  7  Foot  III  85  
Patient  8  Hip  IV  40  
Patient  9  Spine  IV  50  
Patient  10  Knee  III  68  
Patient  11  Hip  IV  38  
Patient  12  Spine  IV  35  
Patient  13  Shoulder  IV  43  
Patient  14  Ankle  IV  43  
Patient  15  Spine  IV  25  
Table  2  Clinical  and  perfusion  characteristics  of  the  lesions  i
Symptoms  Location  
Patient  1  Local  pain  Greater  trochanter  
Patient  2  Post  traumatic  chronic
pain
Distal  ﬁbula  
Patient  3  Inﬂammatory  type  pain  Proximal  humerus  
Patient  4  Local  pain  Tibia  
Patient  5  Inﬂammatory  type  pain  Tibia  
Patient  6  Pain  after  exercise  Greater  trochanter  
Patient  7  Asymptomatic  Distal  femur  
Patient  8  Local  pain  Femur  
Patient  9  Inﬂammatory  type  pain  Pedicle  L5  
Patient  10 Palpable  mass  no  pain  Middle  phalanx  4th  ﬁnge
Patient  11 Pain  after  exercise Tibia  
Patient  12 Diffuse  and  chronic
pain
Ulna 
Patient  13  Local  pain  Proximal  phalanx  3rd  ﬁn
Patient  14  Asymptomatic  Distal  phalanx  hallux  
Patient  15  Local  pain  Femur  P.A.  Gondim  Teixeira  et  al.
Among  the  lesions  included  in  the  other  tumors  group,
here  were  10  chondrosarcomas,  3  giant  cell  tumors,  2
etastasis,  one  conventional  osteosarcoma,  one  enchon-
roma,  one  paraosteal  osteosarcoma,  one  aneurismal  bone
yst,  one  Ewing  tumor,  one  adamantinoma,  one  clear
ell  chondrosarcoma,  one  eosinophilic  granuloma,  one
nicameral  bone  cyst,  one  spindle  cell  sarcoma  and
ne  plasmocytoma.  Eighteen  out  of  25  of  these  tumors
ere  malignant.  Lesion  size  varied  from  3.8  to  24  cm
mean  =  8.4  cm).  There  was  no  preferential  curve  morphol-
gy  for  malignant  or  benign  lesions,  and  none  of  the
erfusion  parameters  evaluate  allowed  this  distinction  in
he  population  studied.  In  all  the  lesions  included  in  this
roup,  conventional  CT  ﬁndings  were  sufﬁcient  to  rule  out
he  diagnosis  of  osteoid  osteoma.  A  table  with  the  histologic
e  osteoid  osteoma  group.
e-to-peak  (s)  Arterial-tumor  peak  delay  (s)
5
25
20
5
15
5
15
5
15
25
11
5
7
5
5
ncluded  in  the  mimickers  group.
Final  diagnosis Histology  Curve  type
No  touch  lesion  No  I
Benign  cortical
hyperostosis
Yes  I
Giant  bone  island  No  I
Systemic  inﬂammatory
disease
Normal  bone  I
Fibro-myxoid
chondroma
Yes  II
Chondroblastoma  Yes  III
Giant  cell  tumor  Yes  II
No  touch  lesion  Normal  bone  II
Systemic  inﬂammatory
disease
No II
r  No  touch  lesion  No  IV
Bone  stress  reaction  No  II
Osteomyelitis  Yes  IV
ger  Encondroma  Yes  II
Encondroma  Yes  I
Chondrosarcoma  Yes  II
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Table  3  Histology  and  perfusion  characteristics  of  the  tumors  included  in  the  other  tumors  group.
Histology  Location  Curve  type  Time-to-peak  (s)  Arterial-tumor
peak  delay  (s)
Adamantinoma  Tibial  diaphysis  II  x  x
Aneurysmal  bone  cyst  Distal  ﬁbula  III  44  9
Chondrosarcoma  Proximal  femur  II  x  x
Chondrosarcoma  Distal  femur  II  x  x
Chondrosarcoma  Proximal  humerus II  x  x
Chondrosarcoma  5th  metatarsal II  x  x
Chondrosarcoma  Distal  femur IV  70  30
Chondrosarcoma  Proximal  femur  III  30  5
Chondrosarcoma  Acetabulum  II  x  x
Chondrosarcoma  Proximal  humerus  I  x  x
Chondrosarcoma  Femoral  diaphysis  III  34  10
Chondrosarcoma  Thumb  II  x  x
Clear  cell  carcinoma  Proximal  humerus  IV  40  0
Enchondroma  Proximal  humerus  II  70  35
Eosinophilic  granuloma  Scapula  II  x  x
Ewing’s  sarcoma  Iliac  wing  III  40  10
Giant  cell  tumor  Distal  femur  II  x  x
Giant  cell  tumor  Distal  femur  IV  45  10
Giant  cell  tumor  Distal  femur  III  36  10
Metastasis  Ischio  pubic  III  37  15
Metastasis  Iliac  wing  III  37  5
Osteosarcoma  Iliac  wing  I  x  x
Paraosteal  osteosarcoma  Iliac  wing  II  x  x
Plasmocytoma  Ischium  IV  30  5
Spindle  cell  sarcoma  Ischio  pubic  IV  46  10
I  
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uUnicameral  bone  cyst  Proximal  humerus  
diagnosis  and  the  perfusion  parameters  studied  in  this  group
is  presented  (Table  3).
Three  of  the  lesions  in  the  other  tumors  group  (11.5%)
did  not  present  a  detectable  enhancement  (curve  type  I).
Among  the  lesions  that  showed  enhancement  in  11  (42.3%),
the  curve  was  classiﬁed  as  type  II  and  12  (46.1%)  were  clas-
siﬁed  as  types  III  or  IV.  In  the  later  lesions  (curve  types  III
or  IV),  the  time-to-peak  varied  from  30  to  70  seconds,  with
a  mean  of  40.7  (±10.6)  seconds.  The  delay  to  the  arterial
peak  varied  from  5-30  seconds  in  this  with  a  mean  of  9.9
(±7.3)  seconds.  The  perfusion  pattern  in  this  group  was  sig-
niﬁcantly  different  than  that  of  the  osteoid  osteoma  group
(P  =  0.0002),  however,  the  difference  between  the  time-to-
peak  and  the  delay  to  the  arterial  peak  was  not  signiﬁcant
(P  =  0.259  and  0.84  respectively).
Among  the  lesions  that  presented  a  curves  type  III  or  IV,
there  were  three  chondrosarcomas,  two  giant  cell  tumors,
one  aneurismal  bone  cysts,  one  clear  cell  sarcoma,  one  spin-
dle  cell  sarcoma,  one  Ewing  sarcoma,  one  plasmocytoma
and  two  metastasis  (adenocarcinoma  and  epidermoid  carci-
noma).  When  other  imaging  features  were  taken  in  account
(lesion  morphology  and  imaging  characteristics  on  conven-
tional  CT  or  MR),  the  differentiation  of  these  lesions  from
osteoid  osteomas  posed  no  difﬁculty.Discussion
CT  perfusion  demonstrated  a  type  III  or  IV  in  all  osteoid
osteomas  studied.  These  lesions  demonstrated  an  early
w
s
w
ix  x
nhancement  with  a  peak  enhancement  shortly  after  the
rterial  peak  (mean  11s).  This  ﬁnding  is  consistent  with
revious  reports  describing  the  enhancement  dynamics  of
steoid  osteomas  on  MR  perfusion  and  is  probably  related  to
ighly  vascular  nature  of  the  nidus  [1,4,8,9,14,15]  (Fig.  1).
he  pattern  of  enhancement  in  the  osteoid  osteomas  group
as  signiﬁcantly  different  than  that  of  the  mimicker’s  and
he  other  tumors  groups.  These  results  demonstrate  that  an
arly  and  steep  enhancement  (types  III  or  IV)  is  indicative  of
steoid  osteomas  but  it  is  not  pathognomonic  of  this  lesion.  A
imilar  pattern  was  found  in  other  lytic  bone  lesions  studied.
If  curve  type  III  or  IV  and  a  short  delay  between  tumor
nd  arterial  peaks  are  considered  as  a  diagnostic  criteria
or  osteoid  osteomas,  CT  perfusion  allowed  to  rule  out  the
iagnosis  of  osteoid  osteomas  in  80%  of  the  lesions  included
n  the  mimickers  group  (Fig.  2).  Nevertheless,  this  type  of
nhancement  was  found  in  a  small  percentage  of  the  osteoid
steoma  mimickers  and  in  those  cases,  the  imaging  ﬁnd-
ngs  were  not  sufﬁcient  to  rule  out  the  diagnosis  of  osteoid
steoma.  Hence,  the  presented  results  demonstrate  that
or  small  lytic  cortical  or  sub-cortical  lesion,  the  absence
f  enhancement  or  a  delayed  enhancement  (curve  type  II)
n  CT  perfusion  makes  the  diagnosis  of  osteoid  osteoma
nlikely.
The  type  of  enhancement  seen  in  osteoid  osteoma  group
as  signiﬁcantly  different  than  that  of  the  other  lytic  lesions
tudied.  In  despite  of  this  difference,  curves  type  III  and  IV
ere  frequently  found  in  the  other  lytic  bone  lesions  stud-
ed.  In  46.1%  of  the  lesions  included  in  the  other  tumors
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Figure 1. 26-year-old male with a biopsy proven osteoid osteoma of the radius. A. Axial CT images demonstrating ROI placement in the
nidus (green ellipsis) and in the nearby radial artery (purple ellipsis). Note the marked periosteal reaction around the lesion. The image
in a white frame on the bottom left of (A) demonstrates the global aspect of the lesion in a coronal oblique CT image. Note the central
calciﬁcation and the reactive bone sclerosis. B. CT perfusion time-to-density curve (Hounsﬁeld units × milliseconds) of the same patient
demonstrating an early and steep enhancement of nidus (green curve) with respect to the artery (purple curve), followed by a washout
(curve type IV).
Figure 2. 54-year-old female with inﬂammatory type lumbar pain. A. Axial CT images demonstrating the ROI placement in a lytic bone
lesion of the right pedicle of the 5th lumbar vertebra (purple circle) and in the right iliac artery (green circle). The picture in the white
frame in (A) shows the global aspect of the lytic lesion (white arrows) surrounded by reactive bone sclerosis. B. CT perfusion time-to-density
curve (Hounsﬁeld units × milliseconds) of the same patient demonstrating a delayed progressive enhancement of the lesion (purple curve)
with respect to the artery (green curve). This lesion disappeared spontaneously in a control CT study performed 3 months later (images not
shown).
Figure 3. 84-year-old male with a biopsy proven spindle cell sarcoma of the left acetabulum and left ischio-pubic branch. A. Axial CT
images demonstrating the ROI placement in a large lytic bone lesion with soft tissue invasion at the level left ischio-pubic branch (green
circle) and in the left femoral artery (purple circle). The white arrowheads delineates the mass contours. B. CT perfusion time-to-density
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roup  an  early  enhancement  (curves  type  III  or  IV)  was
ound  (Fig.  3).  Additionally  there  were  no  signiﬁcant  dif-
erences  in  the  time-to-peak  and  in  the  delay  between
he  arterial  and  nidus  peaks  in  these  two  groups.  In  these
atients,  the  differentiation  from  osteoid  osteomas  was  not
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eing an early and steep enhancement of lesion (green curve) with
IV).
ossible  with  CT  perfusion  alone.  The  diagnosis  of  osteoid
steomas  in  these  patients  was  easily  ruled  out  when  con-
entional  CT  ﬁndings  were  taken  in  consideration,  such  as
umor  size,  surrounding  sclerosis,  periosteal  reaction  and
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Previous  studies  have  suggested  that  an  early  enhance-
ment  is  more  frequent  in  malignant  soft  tissue  lesions  [13].
Bone  tumors  are  a  very  heterogeneous  group  of  pathology
with  respect  to  histology  and  imaging  features  [16].  There
was  no  correlation  between  the  enhancement  pattern  on
CT  perfusion  and  the  histology  in  the  population  studied.
An  early  and  steep  enhancement  like  the  enhancement  pat-
tern  found  in  the  osteoid  osteomas  group  was  found  in  both
benign  and  malignant  lytic  bone  lesions.
This  study  has  limitations  worthy  of  notice.  Histologic
conﬁrmation  was  not  possible  for  all  osteoid  osteomas.  Since
minimally  invasive  percutaneous  ablation  has  been  adopted
as  the  treatment  of  choice  for  osteoid  osteomas  the  rate
of  histologic  conﬁrmation  of  these  lesions  has  dropped  con-
siderably  [17—19].  Clinical  and  imaging  signs  of  osteoid
osteomas  have  been  extensively  described,  and  so  has  the
clinical  response  to  percutaneous  ablation  [1,2,5,19,20].
That,  added  to  the  absence  of  alternative  diagnosis  in  the
bone  biopsies  performed  at  the  time  of  treatment  pro-
vides  sufﬁcient  evidence  to  support  the  diagnosis  of  osteoid
osteoma  in  the  cases  without  histologic  conﬁrmation.  Addi-
tionally  the  perfusion  parameters  found  in  those  cases  was
similar  to  that  of  the  other  osteoid  osteomas  conﬁrmed
histologically  and  to  what  is  described  in  the  literature
[8,9,21].  In  the  mimickers  group,  some  patients  with  benign
appearing  bone  lesion  did  not  have  histologic  conﬁrmation.
In  these  cases,  performing  a  bone  biopsy  (invasive  proce-
dure)  was  deemed  unethical.  There  was  a  small  variation  in
the  number  of  venous  phases  in  the  CT  perfusion  protocol
used.  These  variations  represented  an  attempt  to  optimize
our  protocol,  keeping  radiation  exposure  to  the  lowest  level
possible.  The  variation  in  the  number  of  venous  phases  had
little  inﬂuence  in  the  perfusion  analysis  since  the  perfusion
parameters  evaluated  (time-to-peak,  delay  between  arte-
rial  and  nidus  peak  and  curve  morphology)  related  mostly  to
the  enhancement  on  the  arterial  phase.
In  summary,  an  early  enhancement  with  a  short  delay
between  arterial  and  tumor  peaks  and  curve  morphology
types  III  and  IV  are  suggestive  of  osteoid  osteomas.  Absent
or  delayed  enhancement  (curve  types  I  or  II)  in  lesions  with
morphologic  features  of  osteoid  osteoma  on  conventional
CT  should  evoke  an  alternative  diagnosis.  Although  evoca-
tive  of  osteoid  osteomas,  CT  perfusion  alone  is  not  sufﬁcient
for  to  make  this  diagnosis  since  the  same  contrast  enhance-
ment  dynamics  was  found  in  various  other  lytic  bone  lesions,
both  malignant  and  benign.  CT  perfusion  could  represent  an
option  to  MR  perfusion  in  selected  patients,  especially  when
the  latter  is  not  readily  available.
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